Results 141 to 150 of about 108,448 (307)

Solid‐state fermentation pro‐enzymes supplementation benefits growth performance, health, and intestinal microbiota of broiler chickens fed wheat‐based diet

open access: yesAnimal Research and One Health, EarlyView.
Wheat as a kind of diet material can be used for broiler production. However, due to non‐starch polysaccharides (NSP) in wheat, wheat may lead to lower growth performance and worth health. This experiment used solid‐state fermentation pro‐enzymes (SFP enzymes) to reverse the negative effect of wheat.
Jiaheng Li   +8 more
wiley   +1 more source

Topical Mupirocin Treatment Reduces Interferon and Myeloid Signatures in Cutaneous Lupus Erythematous Lesions Through Targeting of Staphylococcus Species

open access: yesArthritis &Rheumatology, EarlyView.
Objective Cutaneous lupus erythematosus (CLE) is an inflammatory skin manifestation of systemic lupus erythematosus. Type I interferons (IFNs) promote inflammatory responses and are elevated in CLE lesions. We recently reported that CLE lesions are frequently colonized with Staphylococcus aureus.
Lisa Abernathy‐Close   +9 more
wiley   +1 more source

Does high sugar intake really alter the oral microbiota?: A systematic review

open access: yesClinical and Experimental Dental Research, Volume 8, Issue 6, Page 1376-1390, December 2022., 2022
Abstract Objectives Diet is one of the main factors influencing the diversity and interactions of the oral microbiota. The purpose of this study is to determine the impact of sugar intake on the microbial diversity and bacteria that predominate under these conditions.
María del Pilar Angarita‐Díaz   +3 more
wiley   +1 more source

Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess the value of serum type I interferon (IFN) score in predicting clinically meaningful progression in limited cutaneous systemic sclerosis (lcSSc) using a novel composite endpoint adopted from the MINIMISE clinical trial. Methods A retrospective, longitudinal lcSSc cohort was identified within a national, multicenter observational ...
Stefano Di Donato   +9 more
wiley   +1 more source

The changes in levels of blood cortisol, glucose, and oxygen saturation in type 2 diabetic patients during tooth extraction

open access: yesClinical and Experimental Dental Research, Volume 8, Issue 6, Page 1449-1455, December 2022., 2022
Abstract Objectives The extraction of a tooth exacerbates the stress in diabetic patients leading to diabetic complications so the aim was to evaluate the changes in blood cortisol, glucose, and oxygen saturation in type 2 diabetic patients during tooth extraction to pay special attention during a routine surgical procedure.
Zana Agani   +6 more
wiley   +1 more source

Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, relapsing, inflammatory disease. Management of EGPA predominantly relies on oral corticosteroids (OCS), which are associated with many adverse effects. The Phase III MIRRA trial demonstrated efficacy and safety of mepolizumab, anti‐interleukin‐5 biologic, for EGPA.
Michael E Wechsler   +34 more
wiley   +1 more source

Factors related to mouth breathing syndrome in preschool children and the effects of incompetent lip seal: An exploratory study

open access: yesClinical and Experimental Dental Research, Volume 8, Issue 6, Page 1555-1560, December 2022., 2022
Abstract Objectives A set of orofacial signs and symptoms completely or partially present in individuals who replace the correct pattern of nasal breathing with an oral or mixed pattern is defined as mouth breathing syndrome (MBS). In a previous report, it was clarified that an incompetent lip seal (ILS) affected the occurrence of MBS among primary ...
Emi Inada   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy